buy peptides retatrutide (RETA) – Research Peptide Retatrutide 20mg / 30mg /

Note: As Retatrutide remains under investigation through ongoing clinical trials, it has not yet received MHRA approval and is not currently authorised for routine prescribing in the UK

Nausea was reported in approximately 4060% of participants in the mid-to-high dose groups (8 mg and 12 mg), with lower rates observed in participants receiving the smallest doses or following slower titration schedules

At Doctor Tony Clinic, we recommend starting with a lower dosage and gradually increasing it as your body becomes accustomed to the treatment

Baseline assessment helps determine if lifestyle-first strategies are sufficient or if additional support is warranted